REDWOOD SCIENTIFIC TECHNOLOGIES, INC. (RSCI)
| Symbol | RSCI |
|---|
| Name | REDWOOD SCIENTIFIC TECHNOLOGIES, INC. |
|---|
| Sector | UNDEFINED |
|---|
| Region | North America |
|---|
| Industry | - |
|---|
| Address | 12207 United States NY 418 Broadway, STE 4872 |
|---|
| Telephone | +1 4128482757 |
|---|
| Fax | — |
|---|
| Email | — |
|---|
| Website | http://www.redwoodsci.co |
|---|
| Incorporation | US |
|---|
| Incorporated On | 1986 |
|---|
| Employees | — |
|---|
| Fiscal Year | 12/31 |
|---|
| Public Since | — |
|---|
| Exchanges | OTC |
|---|
| Auditor | Victor Mokuolu, CPA PLLC; |
|---|
| Audit Status | AUDITED |
|---|
| Reporting Status | Dark: Alternative Reporting Standard |
|---|
| CIK | 0001634394 |
|---|
| Description | Redwood Scientific Technologies (RSCI) is a pharmaceutical company that develops,
operates, and markets innovative over-the-counter products in a sublingual oral thin film
strip. RSCI has begun clinical trials on two new products that will be marketed to help
stop the addiction to nicotine. Redwood will bring back its product TBX-FREE for the
addiction to nicotine in cigarettes. Redwood will also begin a trial on a product to stop
the addiction to nicotine in vape delivery. Redwood Scientific is targeting the clinical trials
that will conclude in 2024.
Additional info from OTC:
Redwood Scientific Technologies (RSCI) is a pharmaceutical company that develops,
operates, and markets innovative over-the-counter products in a sublingual oral thin film
strip. RSCI has begun clinical trials on two new products that will be marketed to help
stop the addiction to nicotine. Redwood will bring back its product TBX-FREE for the
addiction to nicotine in cigarettes. Redwood will also begin a trial on a product to stop
the addiction to nicotine in vape delivery. Redwood Scientific is targeting the clinical trials
that will conclude in 2024. |
|---|